(Q42949809)

11 November 2017

title

Simvastatin-induced changes in circulating oxidized low-density lipoprotein in different types of dyslipidemia (English)

1 reference

11 November 2017

1 reference

1 reference

Anna Tavridou

1

1 reference

11 November 2017

Apostolos Efthimiadis

series ordinal

2

1 reference

11 November 2017

Ioannis Efthimiadis

series ordinal

3

1 reference

11 November 2017

Vangelis G. Manolopoulos

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20676836

14 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20676836

14 June 2024

publication date

31 July 2010

1 reference

full work available at URL

11 November 2017

http://link.springer.com/content/pdf/10.1007/s00380-009-1202-x.pdf

file format

Portable Document Format

1 reference

DOI

https://api.crossref.org/works/10.1007/S00380-009-1202-X

http://link.springer.com/article/10.1007/s00380-009-1202-x/fulltext.html

14 June 2024

1 reference

https://api.crossref.org/works/10.1007/S00380-009-1202-X

http://link.springer.com/content/pdf/10.1007/s00380-009-1202-x

14 June 2024

1 reference

DOI

https://api.crossref.org/works/10.1007/S00380-009-1202-X

14 June 2024

1 reference

11 November 2017

volume

25

1 reference

11 November 2017

issue

4

1 reference

11 November 2017

page(s)

288-293

1 reference

Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity

11 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00380-009-1202-X

Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-009-1202-X

Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-009-1202-X

Oxidized low-density lipoprotein in plasma is a prognostic marker of subclinical atherosclerosis development in clinically healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-009-1202-X

Is the oxidative modification hypothesis relevant to human atherosclerosis? Do the antioxidant trials conducted to date refute the hypothesis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-009-1202-X

Statins in atherosclerosis: lipid-lowering agents with antioxidant capabilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-009-1202-X

Simvastatin lowers C-reactive protein within 14 days: an effect independent of low-density lipoprotein cholesterol reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-009-1202-X

High-sensitivity C-reactive protein and cardiovascular risk: rationale for screening and primary prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-009-1202-X

Effects of conventional and aggressive statin treatment on markers of endothelial function and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-009-1202-X

A comparative study of the in vitro antioxidant activity of statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-009-1202-X

Lipid-lowering therapy with fluvastatin inhibits oxidative modification of low density lipoprotein and improves vascular endothelial function in hypercholesterolemic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-009-1202-X

Antioxidant properties of two novel 2-biphenylmorpholine compounds (EP2306 and EP2302) in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-009-1202-X

Lipid-altering changes and pleiotropic effects of atorvastatin in patients with hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-009-1202-X

Oxidized LDL and thickness of carotid intima-media are associated with coronary atherosclerosis in middle-aged men: lower levels of oxidized LDL with statin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-009-1202-X

In vivo markers of oxidative stress and therapeutic interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-009-1202-X

Oxidative modification of triacylglycerol-rich lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-009-1202-X

Ratio of triglycerides to HDL cholesterol is an indicator of LDL particle size in patients with type 2 diabetes and normal HDL cholesterol levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-009-1202-X

Impact of postprandial lipaemia on low-density lipoprotein (LDL) size and oxidized LDL in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-009-1202-X

Serum levels of remnant lipoprotein cholesterol and oxidized low-density lipoprotein in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-009-1202-X

Low serum adiponectin is associated with high circulating oxidized low-density lipoprotein in patients with type 2 diabetes mellitus and coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-009-1202-X

Effects of atorvastatin on oxidized low-density lipoprotein, low-density lipoprotein subfraction distribution, and remnant lipoprotein in patients with mixed hyperlipoproteinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-009-1202-X

Atorvastatin induces associated reductions in platelet P-selectin, oxidized low-density lipoprotein, and interleukin-6 in patients with coronary artery diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-009-1202-X

Effects of simvastatin on plasma antioxidant status and vitamins in hypercholesterolemic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-009-1202-X

Effects of statins on nonlipid serum markers associated with cardiovascular disease: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-009-1202-X

Synergistic effect of amlodipine and atorvastatin on blood pressure, left ventricular remodeling, and C-reactive protein in hypertensive patients with primary hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-009-1202-X

Circulating levels of autoantibodies to oxidized low-density lipoprotein and C-reactive protein levels correlate with endothelial function in resistance arteries in men with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-009-1202-X

Association of high coronary heart disease risk status with circulating oxidized LDL in the well-functioning elderly: findings from the Health, Aging, and Body Composition study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-009-1202-X

Circulating oxidized LDL is associated with subclinical atherosclerosis development and inflammatory cytokines (AIR Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-009-1202-X

Measures of oxidized low-density lipoprotein and oxidative stress are not related and not elevated in otherwise healthy men with the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-009-1202-X

Relationship between biomarkers of oxidized low-density lipoprotein, statin therapy, quantitative coronary angiography, and atheroma: volume observations from the REVERSAL (Reversal of Atherosclerosis with Aggressive Lipid Lowering) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-009-1202-X

Oxidative stress evaluated using an automated method for hydroperoxide estimation in patients with coronary artery disease

21 January 2018

1 reference

12 December 2020

Bioavailability and antioxidant activity of some food supplements in men and women using the D-Roms test as a marker of oxidative stress

1 reference

12 December 2020

Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B

1 reference

12 December 2020

How different constituents of low density lipoprotein determine its oxidizability by copper: a correlational approach

1 reference

12 December 2020

Autoantibody titers against OxLDL are correlated with Achilles tendon thickness in patients with familial hypercholesterolemia

1 reference

12 December 2020

Performance and clinical application of a new, fast method for the detection of hydroperoxides in serum.

1 reference

12 December 2020

Effect of simvastatin therapy on paraoxonase activity and related lipoproteins in familial hypercholesterolemic patients

1 reference

12 December 2020

Lipid compositional differences of small, dense low-density lipoprotein particle influence its oxidative susceptibility: possible implication of increased risk of coronary artery disease in subjects with phenotype B

1 reference

12 December 2020

Elevated hydroperoxide levels as a prognostic predictor of mortality in a cohort of patients with cardiovascular disease

1 reference

12 December 2020

Beneficial effect of simvastatin treatment on LDL oxidation and antioxidant protection is more pronounced in combined hyperlipidemia than in hypercholesterolemia

1 reference

12 December 2020

Reproducibility of blood markers of oxidative status and endothelial function in healthy individuals

1 reference

12 December 2020

Direct vascular effects of HMG-CoA reductase inhibitors

1 reference

12 December 2020

Reduced susceptibility of low density lipoprotein (LDL) to lipid peroxidation after fluvastatin therapy is associated with the hypocholesterolemic effect of the drug and its binding to the LDL

1 reference

12 December 2020

Identifiers

DOI

1 reference

Dimensions Publication ID

11 November 2017

1024715791

0 references

1 reference